{"nctId":"NCT03231371","briefTitle":"Coronary Artery Vasculopathy in Pediatric Heart Transplant Patients","startDateStruct":{"date":"2008-11"},"conditions":["Orthotopic Heart Transplant"],"count":22,"armGroups":[{"label":"Study Arm","type":"EXPERIMENTAL","interventionNames":["Drug: Adenosine"]}],"interventions":[{"name":"Adenosine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients age 1 - 25 years who are status-post OHT (â‰¤18 years at the time of transplantation) and undergoing routine post-transplant surveillance catheterization for endomyocardial biopsy and coronary angiography\n\nExclusion Criteria:\n\n* The presence of sick sinus syndrome or 2nd or 3rd degree atrioventricular block (without a functioning implanted pacemaker)\n* Hemodynamically significant valvular disease\n* Severe asthma or bronchospasm, known severe CAV\n* Pulmonary hypertension.\n* Patients taking digoxin\n* Verapamil and dipyridamole are also excluded given known interactions with adenosine.","healthyVolunteers":false,"sex":"ALL","minimumAge":"1 Year","maximumAge":"25 Years","stdAges":["CHILD","ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Coronary Flow Reserve (CFR)","description":"Ratio of peak to baseline coronary flow velocity (CFV)","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1.77","spread":"2.62"}]}]}]},{"type":"SECONDARY","title":"Gadolinium Enhancement by Cardiac MRI","description":"Categorical measure - yes or no; number of participants with gadolinium enhancement","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":22},"commonTop":["Transient Atrial Ventricular block, self-resolved without intervention"]}}}